Post-traumatic stress disorder (PTSD) is a mental health condition that’s triggered by a terrifying event — either experiencing it or witnessing it.
PTSD can occur in anyone who experiences or witnesses a traumatic event, such as a natural disaster, a serious accident, a terrorist act, war/combat, rape, or other violent personal assault. PTSD can also be caused by ongoing events or situations that leave a person feeling unsafe for any length of time, such as ongoing physical or sexual abuse, childhood neglect, and bullying.
Most people who go through a traumatic event will have reactions that may include shock, anger, nervousness, fear and even guilt. But with time and proper self-care, many will recover from the initial symptoms on their own. If the symptoms get worse, seem to be triggered by certain things, last for months or even years, and interfere with day-to-day functioning, it is most likely PTSD.
Daytryp specializes in utilizing the power of psychedelic therapies as highly effective and scientifically supported treatment options for individuals dealing with post-traumatic stress disorder (PTSD). Our approach offers renewed hope, particularly for those who have found limited relief from traditional treatments. With a compassionate and knowledgeable team, we guide each client on a transformative healing journey.
Under the careful medical supervision of our experts, our mission is to help you unlock your potential by utilizing psychedelic therapies to address the underlying causes of PTSD and foster new perspectives on healing and resilience. We provide the necessary resources and support to empower you in making lasting changes that promote emotional well-being, reduce symptoms, and enhance your overall quality of life.
Research shows that ketamine is highly effective in treating PTSD, as well as depression, addiction, alcoholism, anxiety, chronic pain, suicidal ideation, migraines, and eating disorders. A study published in 2016 found that a single dose of ketamine was associated with a reduction in symptoms of PTSD, including re-experiencing, avoidance, and numbing. Up to 75% of people with PTSD experienced relief of symptoms following ketamine treatment.
3,4-methylenedioxy-methamphetamine (MDMA) therapy is an upcoming, highly effective and innovative treatment approach for those suffering from post-traumatic stress disorder (PTSD) and other mental health conditions. It combines the psychoactive compound MDMA with guided psychological support, and has shown as much as a 75% success rate in patients suffering from PTSD, setting an unprecedented standard for treatment. MDMA therapy is not currently available, but expected to gain FDA approval later this year.